| Id |
Subject |
Object |
Predicate |
Lexical cue |
| T1 |
0-78 |
Sentence |
denotes |
Biomarkers of Endothelial Dysfunction in Women With Polycystic Ovary Syndrome. |
| T1 |
0-78 |
Sentence |
denotes |
Biomarkers of Endothelial Dysfunction in Women With Polycystic Ovary Syndrome. |
| T2 |
79-179 |
Sentence |
denotes |
Polycystic ovary syndrome (PCOS) is the most common endocrine disorder in women of childbearing age. |
| T2 |
79-179 |
Sentence |
denotes |
Polycystic ovary syndrome (PCOS) is the most common endocrine disorder in women of childbearing age. |
| T3 |
180-334 |
Sentence |
denotes |
The criteria required for the diagnosis identify various phenotypes, with different reproductive, metabolic, and cardiovascular (CV) risk characteristics. |
| T3 |
180-334 |
Sentence |
denotes |
The criteria required for the diagnosis identify various phenotypes, with different reproductive, metabolic, and cardiovascular (CV) risk characteristics. |
| T4 |
335-498 |
Sentence |
denotes |
Emerging evidence links adipocyte-secreted hormones as candidates in the pathogenesis of endothelial dysfunction in PCOS, independently of additional risk factors. |
| T4 |
335-498 |
Sentence |
denotes |
Emerging evidence links adipocyte-secreted hormones as candidates in the pathogenesis of endothelial dysfunction in PCOS, independently of additional risk factors. |
| T5 |
499-737 |
Sentence |
denotes |
The aim of this review was to collect, analyze, and qualitatively resynthesize evidence on biomarkers of endothelial dysfunction (visfatin, vascular endothelial growth factor [VEGF], matrix metalloproteinase 9 [MMP-9]) in women with PCOS. |
| T5 |
499-737 |
Sentence |
denotes |
The aim of this review was to collect, analyze, and qualitatively resynthesize evidence on biomarkers of endothelial dysfunction (visfatin, vascular endothelial growth factor [VEGF], matrix metalloproteinase 9 [MMP-9]) in women with PCOS. |
| T6 |
738-1152 |
Sentence |
denotes |
Women with PCOS exhibit (a) increased plasma visfatin concentrations compared with controls with a similar body mass index; (b) increased VEGF production along with chronic, mild inflammation; and (c) increased MMP-9 concentrations, which might be related to either excessive CV risk or abnormalities of ovarian extracellular matrix remodeling, multiple cyst formation, follicular atresia, and chronic anovulation. |
| T6 |
738-1152 |
Sentence |
denotes |
Women with PCOS exhibit (a) increased plasma visfatin concentrations compared with controls with a similar body mass index; (b) increased VEGF production along with chronic, mild inflammation; and (c) increased MMP-9 concentrations, which might be related to either excessive CV risk or abnormalities of ovarian extracellular matrix remodeling, multiple cyst formation, follicular atresia, and chronic anovulation. |
| T7 |
1153-1266 |
Sentence |
denotes |
As PCOS has been associated with CV risk, early identification of endothelial dysfunction is clinically relevant. |
| T7 |
1153-1266 |
Sentence |
denotes |
As PCOS has been associated with CV risk, early identification of endothelial dysfunction is clinically relevant. |